Pathophysiological Mechanisms and Advances in Diagnosis and Treatment of Cardiorenal Syndrome: A Comprehensive Review
Journal: Journal of Clinical Medicine Research DOI: 10.32629/jcmr.v4i4.1354
Abstract
Cardiorenal syndrome (CRS) is a syndrome in which acute and chronic functional abnormalities occur in one organ of the heart and kidney, leading to acute and chronic functional abnormalities in the other organ.The clinical diagnosis and treatment of CRS has its own specificity, and its pathophysiological mechanism is relatively complex.This paper provides an overview of the pathophysiological mechanism of CRS, the speciality of diagnosis and treatment of CRS, and progress in the target of injury markers in order to provide new ideas for clinical treatment. This paper summarizes the pathophysiology and pathogenesis of CRS, its diagnosis and treatment, and the progress of damage marker targets, in order to provide new ideas for clinical treatment.
Keywords
cardiorenal syndrome, heart failure, renal failure, mechanisms
Full Text
PDF - Viewed/Downloaded: 3 TimesReferences
[1]Torres V B,García F I,Guillén O O, et al. EP13.45: Evaluation of fetal growth in pregnant women with cardiorenal syndrome type 2[J]. Ultrasound in Obstetrics & Gynecology,2023,62.
[2]A J C,B M B,A D B, et al. Safety and Performance of the Aortix Device in Acute Decompensated Heart Failure and Cardiorenal Syndrome.[J]. JACC. Heart failure,2023.
[3]Emeli C,S R R,J V K, et al. Circulating extracellular vesicles in human cardiorenal syndrome promote renal injury in Kidney on Chip system.[J]. JCI insight,2023.
[4]Jonathan N,Meike H,Oliver L, et al. NT-proBNP/urine hepcidin-25 ratio and cardiorenal syndrome type 1 in patients with severe symptomatic aortic stenosis.[J]. Biomarkers in medicine,2023.
[5]Wendy Q W Y,Azfar M Q,Bourne A. Cardiorenal syndrome.[J]. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,2023,195(34).
[6]K A G,B D S. Neuregulin-1: A Tonic for Cardiorenal Syndrome? And All Else That Ails Us?[J]. JACC. Basic to translational science,2023,8(9).
[7]Georgia D,Georgios S,Panagiotis T, et al. Cardiorenal syndrome and iron supplementation-more benefits than risks: a narrative review.[J]. International urology and nephrology,2023.
[8]Pieter M,Daniel B,A J C, et al. Emerging Individualized Approaches in the Management of Acute Cardiorenal Syndrome With Renal Assist Devices.[J]. JACC. Heart failure,2023,11(10).
[9]Điđi D,Tanja B,Ingrid P. Diagnostic value and utility of commonly used biomarkers of cardiac and renal function in cardiorenal syndromes: a narrative review.[J]. Biochemia medica,2023,33(3).
[2]A J C,B M B,A D B, et al. Safety and Performance of the Aortix Device in Acute Decompensated Heart Failure and Cardiorenal Syndrome.[J]. JACC. Heart failure,2023.
[3]Emeli C,S R R,J V K, et al. Circulating extracellular vesicles in human cardiorenal syndrome promote renal injury in Kidney on Chip system.[J]. JCI insight,2023.
[4]Jonathan N,Meike H,Oliver L, et al. NT-proBNP/urine hepcidin-25 ratio and cardiorenal syndrome type 1 in patients with severe symptomatic aortic stenosis.[J]. Biomarkers in medicine,2023.
[5]Wendy Q W Y,Azfar M Q,Bourne A. Cardiorenal syndrome.[J]. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,2023,195(34).
[6]K A G,B D S. Neuregulin-1: A Tonic for Cardiorenal Syndrome? And All Else That Ails Us?[J]. JACC. Basic to translational science,2023,8(9).
[7]Georgia D,Georgios S,Panagiotis T, et al. Cardiorenal syndrome and iron supplementation-more benefits than risks: a narrative review.[J]. International urology and nephrology,2023.
[8]Pieter M,Daniel B,A J C, et al. Emerging Individualized Approaches in the Management of Acute Cardiorenal Syndrome With Renal Assist Devices.[J]. JACC. Heart failure,2023,11(10).
[9]Điđi D,Tanja B,Ingrid P. Diagnostic value and utility of commonly used biomarkers of cardiac and renal function in cardiorenal syndromes: a narrative review.[J]. Biochemia medica,2023,33(3).
Copyright © 2023 Yuanyu Tian, Xiaoli Zhou
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License